Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy
To evaluate the role of central subfield thickness (CST), cube average thickness (CAT), and cube volume (CV) as imaging biomarkers for severity of diabetic retinopathy within the ETDRS-based grades of retinopathy using spectral domain optical coherence tomography (SD-OCT). This study aims to evaluate the role of macular CST, CAT, and CV on SD-OCT as imaging biomarkers for severity of DR. One hundred ninety-four consecutive cases of type 2 diabetes mellitus were divided according to ETDRS classification: diabetes mellitus without retinopathy (No DR; n = 65), nonproliferative diabetic retinopathy (NPDR; n = 66), and proliferative diabetic retinopathy (PDR; n = 63). Sixty-three healthy controls were included. CST, CAT, and CV were analyzed using SD-OCT. Data were analyzed statistically. Analysis of variance revealed a significant increase in levels of CST, CAT, CV, and LogMAR visual acuity with the increase in severity of DR. Independent t-test revealed significant difference in CST, CAT, and CV between cases with DME and cases without DME. On multivariate linear regression analysis, increase in CST, CAT, and CV were found to indicate the increase in severity of DR. SD-OCT-based imaging biomarkers CST, CAT, and CV are effective tools for documenting the severity of diabetic retinopathy. These imaging biomarkers serve as significant indicators of severity of disease.
KeywordsDiabetic retinopathy Diabetic macular edema Central subfield thickness Cube average thickness Cube volume Spectral-domain optical coherence tomography
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from all individual participants included in the study.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.A.M. Joussen, V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S.J. Wiegand, J. Rudge, G.D. Yancopoulos, A.P. Adamis, Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160, 501–509 (2002)CrossRefGoogle Scholar
- 4.B.O. Boehm, S. Schilling, S. Rosinger, G.E. Lang, G.K. Lang, R. Kientsch-Engel, P. Stahl, Elevated serum levels of N ε-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 47, 1376–1379 (2004)CrossRefGoogle Scholar
- 10.Diabetic Retinopathy Clinical Research Network, D.J. Browning, A.R. Glassman, L.P. Aiello, R.W. Beck, D.M. Brown, D.S. Fong, N.M. Bressler, R.P. Danis, J.L. Kinyoun, Q.D. Nguyen, A.R. Bhavsar, J. Gottlieb, D.J. Pieramici, M.E. Rauser, R.S. Apte, J.I. Lim, P.H. Miskala, Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114, 525–536 (2007)CrossRefGoogle Scholar
- 11.S. Ruia, S. Saxena, Targeted screening of macular edema by spectral domain optical coherence tomography for progression of diabetic retinopathy. Indian J. Ocul. Biol. 1, 102 (2016)Google Scholar
- 16.H. Faghihi, S. Faghihi, F. Ghassemi, Measurement of normal macular thickness using cirrus optical coherence tomography instrument in Iranian subjects with normal ocular condition. Iran. J. Ophthalmol. 25, 107–114 (2013)Google Scholar
- 18.G. Virgili, F. Menchini, V. Murro, E. Peluso, F. Rosa, G. Casazza, Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst. Rev. 7, CD008081 (2011)Google Scholar
- 19.A. Jain, S. Saxena, V.K. Khanna, R.K. Shukla, C.H. Meyer, Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol. Vis. 19, 176017–176068 (2013)Google Scholar
- 24.J. Liang, W. Lei, J. Cheng, Correlations of blood lipids with early changes in macular thickness in patients with diabetes. J. Fr. Ophtalmol. S0181-5512(18)30537-0 (2019).Google Scholar
- 25.S. Saxena, S. Ruia, S. Prasad, A. Jain, N. Mishra, S.M. Natu, C.H. Meyer, J.S. Gilhotra, P. Kruzliak, L. Akduman, Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 diabetes mellitus. Retina 37, 344–349 (2017)CrossRefGoogle Scholar
- 30.J. Olson, P. Sharp, K. Goatman, G. Prescott, G. Scotland, A. Fleming, S. Philip, C. Santiago, S. Borooah, D. Broadbent, V. Chong, P. Dodson, S. Harding, G. Leese, C. Styles, K. Swa, H. Wharton, Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol. Assess. 17, 1–142 (2013)CrossRefGoogle Scholar